Price
$17.73
Decreased by -2.69%
Dollar volume (20D)
99.25 M
ADR%
7.97
Earnings report date
Oct 28, 2025
Shares float
116.13 M
Shares short
25.73 M [22.16%]
Shares outstanding
742.67 M
Market cap
13.53 B
Beta
-0.95
Price/earnings
N/A
20D range
16.03 28.28
50D range
15.55 36.91
200D range
10.98 36.91

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer.

The company was founded in 2003 and is headquartered in Miami, Florida.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Apr 29, 25 -0.07
Decreased by -12.83%
-0.07
Increased by +0.73%
Dec 31, 24 -0.06
Decreased by -5.50%
-0.06
Decreased by -3.26%
Oct 30, 24 -0.08
Decreased by -100.00%
-0.07
Decreased by -14.29%
Aug 6, 24 -0.09
Decreased by -72.41%
-0.06
Decreased by -50.00%
Jun 14, 24 -0.06
Decreased by -100.00%
-0.06
May 1, 24 -0.06
Decreased by -96.72%
-0.06
Mar 12, 24 -0.04
Decreased by -100.00%
-
Feb 20, 24 -0.05
Decreased by -147.39%
-
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Mar 31, 25 0.00
Decreased by N/A%
-62.91 M
Decreased by -44.72%
Decreased by N/A%
-
Dec 31, 24 0.00
Decreased by N/A%
-61.20 M
Decreased by -40.78%
Decreased by N/A%
Decreased by N/A%
Sep 30, 24 0.00
Increased by +100.00%
-56.25 M
Decreased by -53.84%
Decreased by N/A%
Decreased by N/A%
Jun 30, 24 0.00
Increased by +100.00%
-60.38 M
Decreased by -65.14%
Decreased by N/A%
Decreased by N/A%
Apr 30, 24 N/A
Decreased by N/A%
-43.47 M
Decreased by -104.41%
- -
Mar 31, 24 0.00
Decreased by N/A%
-43.47 M
Decreased by -104.41%
Decreased by N/A%
Decreased by N/A%
Jan 31, 24 -235.00 K
Decreased by -200.00%
-36.57 M
Decreased by -148.47%
Increased by +15.56 K%
Increased by +348.47%
Dec 31, 23 -235.00 K
Decreased by -200.00%
-36.57 M
Decreased by -148.47%
Increased by +15.56 K%
Increased by +348.47%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY